A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02).
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2021